U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
MESMULOGENE ANCOVACIVEC
INN  
Official Name English
TG 4010 [WHO-DD]
Common Name English
mesmulogene ancovacivec [INN]
Common Name English
MVA-MUC1-IL2 (MESMULOGENE ANCOVACIVEC)
Common Name English
AN ANTITUMOR VACCINE CONTAINING A RECOMBINANT MODIFIED VIRUS ANKARA EXPRESSING INTERLEUKIN 2 AND THE TUMOR-ASSOCIATED ANTIGEN MUC1
Common Name English
TG4010
Code English
TG-4010
Code English
Code System Code Type Description
NCI_THESAURUS
C2241
Created by admin on Sat Dec 16 18:24:41 UTC 2023 , Edited by admin on Sat Dec 16 18:24:41 UTC 2023
PRIMARY
FDA UNII
WQQ9XZH2CC
Created by admin on Sat Dec 16 18:24:41 UTC 2023 , Edited by admin on Sat Dec 16 18:24:41 UTC 2023
PRIMARY
CAS
1246525-59-6
Created by admin on Sat Dec 16 18:24:41 UTC 2023 , Edited by admin on Sat Dec 16 18:24:41 UTC 2023
PRIMARY
INN
10254
Created by admin on Sat Dec 16 18:24:41 UTC 2023 , Edited by admin on Sat Dec 16 18:24:41 UTC 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966